Med-El USA’s OtoPlan Wins Hearing Technology Innovator Award
Med-El USA was honored with a Hearing Technology Innovator Award for OtoPlan in the cochlear implant category.
Med-El USA was honored with a Hearing Technology Innovator Award for OtoPlan in the cochlear implant category.
The U.S. cochlear implant market will reach $940.1 million by 2030, fueled by rising awareness, FDA approvals, and growing demand for CIs.
The Widex SmartRIC hearing aid took home a top prize in the 2024 Hearing Technology Innovator Awards.
University Hospitals Cleveland Medical Center and UH Rainbow Babies and Children’s Hospital are participating in a Cochlear Americas’-sponsored clinical trial for an implantable hearing device in children 5 to 11 years of age who have been born with hearing loss that may be caused by craniofacial abnormalities.
A new study highlighted advancements, challenges, and breakthroughs in fully implanted cochlear implants (FICI).
Envoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced an independent study that was published online in 'The Journal of Laryngology & Otology.' The study found that the fully implanted Esteem osseointegrated active middle ear implant (AMEI) showed “statistically significant improvements in post-operative hearing results,” according to Envoy.